PATENT CLAIM ANALYSIS

Application Number: 16034002
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["544", "238000"]

Abstract:
The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1′-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.

Claim (Index 34):
A crystalline form of 1-{4-[1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea characterized by an X-ray powder diffraction pattern substantially as depicted in  FIG. 2 .

Metadata:
- Claim Count in Document: 47.0
- Percentile: 95.0
- Lexical Diversity: 1.7451
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14432188', '15481505', '10544069', '11848939', '14402608']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8066650199895364
- 35 USC 102 Novelty (BERT): 0.6651107852004924
- Combined Prediction Score: 0.792509596510632
- Mean Citation Score: 506.572214
- Max Citation Score: 719.1614
- Similarity Product: 610.8112301911116

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test